Phaarmasia Limited.

BSE: PHRMASI523620ISIN INE486I01016

Healthcare
Pharmaceuticals

BSE listing

Share price

₹88.00-1.00 (-1.12%)

as of 18 Sep 2026

52W high: ₹131.75
52W low: ₹30.01
Off 52W high: -33.21%
1M return: +23.51%
3M return: -11.36%
6M return: +10.33%
1Y return: +122.05%
20D avg volume: 1,221
50 DMA: ₹86.32
200 DMA: ₹90.17

Key ratios Standalone

Market cap: ₹60.08 Cr
Current price: ₹88.00
52W high / low: ₹131.75 / ₹30.01
Face value: ₹10.00
P/E: 3.40
P/B: 6.05
EPS (TTM): ₹25.85
Book value / share: ₹14.55
ROE: 177.64%
ROCE: 96.70%
Operating margin: 4.21%
Net margin: 4.09%
Debt / equity: 0.05
Net debt: ₹0.80 Cr
Interest cover: 98.23
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 57.0 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q4 FY24
Income statement
	8.28	7.73	16.05	16.55	6.87	5.43	—
	0.30	0.34	0.16	0.14	0.32	0.18	—
	8.28	8.61	15.29	14.99	6.88	6.13	—
	6.11	6.08	8.47	13.00	5.67	3.98	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.54	0.95	0.88	0.63	0.43	0.64	—
	0.01	0.18	0.02	0.00	0.03	0.00	—
	0.03	0.04	0.06	0.05	0.06	0.08	—
	1.83	1.17	2.49	3.82	1.45	1.23	—
	0.30	-0.54	0.92	1.70	0.31	-0.51	—
	0.00	0.00	19.00	0.00	0.00	0.00	—
	0.30	-0.54	19.92	1.70	0.31	-0.51	—
	-0.03	0.17	3.64	-0.04	0.04	0.01	—
	0.34	-0.70	16.27	1.74	0.27	-0.53	—
	0.50	-1.03	23.84	2.54	0.40	-0.77	—
Key metrics
	0.34	-0.32	20.00	1.75	0.40	-0.43	—
	4.10%	-4.10%	124.60%	10.60%	5.80%	-7.90%	—
	4.10%	-9.10%	101.40%	10.50%	3.90%	-9.80%	—
	—	-1.60%	—	15.50%	—	-5.70%	—
	20.50%	42.40%	—	—	—	—	—
	25.90%	-32.10%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	48.61	47.21	24.37	—
	0.94	0.96	0.75	—
	47.17	45.77	26.72	—
	33.66	33.22	18.38	—
	0.00	0.00	0.00	—
	3.00	2.89	1.91	—
	0.21	0.22	0.02	—
	0.18	0.21	0.32	—
	9.31	8.94	5.01	—
	2.38	2.40	-1.60	—
	19.00	18.99	0.00	—
	21.38	21.39	-1.60	—
	3.74	3.81	-0.01	—
	17.65	17.57	-1.59	—
	25.85	25.74	-2.33	—
Key metrics
	21.77	21.82	-1.26	—
	44.79%	46.20%	-5.20%	—
	36.31%	37.20%	-6.50%	—
	—	96.70%	-17.70%	—
	—	93.70%	—	—
	—	1,205.00%	—	—
	—	-16.41	-0.17	—
	—	-0.93	0.00	—
	—	0.05	0.00	—
	—	0.80	-0.21	—
	—	57.0	-86.7	—
Balance sheet
	—	30.06	21.56	—
	—	26.74	8.21	—
	—	0.32	0.21	—
	—	5.13	3.11	—
	—	4.36	3.06	—
	—	6.25	1.68	—
	—	1.03	12.28	—
	—	2.12	11.96	—
	—	7.72	12.61	—
	—	1.12	0.00	—
	—	1.12	0.00	—
	—	0.00	0.00	—
	—	22.10	8.74	—
Cash flow
	—	-16.41	0.00	—
	—	26.15	-0.12	—
	—	0.89	-0.15	—
	—	0.00	0.17	—

Compounded growth

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding: 73.52%

Holder	Type	Holding	Previous	Change
MANEESH PHARMACEUTICALS LIMITED	Promoter	44.22%	—	—
SVIZERA LABS PVT LTD	Promoter	29.30%	—	—
MADHAVI PRADEEP SAVE	Public	1.73%	—	—
SHUBHADA GODAMBE ATUL	Public	1.73%	—	—
KALPANA PATANKAR	Public	1.65%	—	—
AMRUTA NISHANT KALSEKAR	Public	1.49%	—	—

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

The Exchange has Sought clarification from Phaarmasia Limited on 31st August, 2026 with reference to Significant Movement in price in order to ensure that investors have latest information ....4 Sep 2026 · Company Update / General
The Exchange has sought Clarification from Phaarmasia Limited on 31st August, 2026 with reference to Price Movement, in order to ensure that investors have relevant information about the company.3 Sep 2026 · Company Update / General
Newspaper Advertisement for Notice of AGM to be held to 25th September, 20263 Sep 2026 · Company Update / Newspaper Publication
Submission of Annual Report for the Financial Year 2025-263 Sep 2026 · Others / Reg. 34 (1) Annual Report
Intimation of 45th Annual General Meeting of Phaarmasia Limited to be held on Friday, 25th September, 2026 at 04.00 PM(IST)3 Sep 2026 · AGM/EGM / AGM
The Exchange has sought clarification from Phaarmasia Ltd on August 31, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant information ....31 Aug 2026 · Company Update / Clarification
Newspaper Advertisement of the un-audited financial results for the Quarter ended 30th June 2026.14 Aug 2026 · Company Update / Newspaper Publication
Submission of Integrated Financial for the Quarter ended 30th June, 202613 Aug 2026 · Result / Financial Results
Submission of Financial Results for the Quarter ended 30th June, 202613 Aug 2026 · Result / Financial Results
Submission of Outcome of Board Meeting held on Thursday, 13th August 2026 started at 05.00 PM (IST)and concluded at 05.45 PM(IST) for Approval of Unaudited Financial Statements for the ....13 Aug 2026 · Board Meeting / Outcome of Board Meeting
Phaarmasia Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve 1. To consider, approve and take ....10 Aug 2026 · Board Meeting / Board Meeting
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the Quarter ended June 30th, 202616 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Closure of Trading window under Reg 30 of SEBI (LODR) Reg 2015 for the Quarter ended June 30, 202627 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
The exchange has sought clarification from Phaarmasia Ltd on 10th June 2026 with reference to significant movement in price, in order to ensure that investors have the latest relevant information ....13 Jun 2026 · Company Update / General
The Exchange has sought clarification from Phaarmasia Ltd on June 10, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant information ....10 Jun 2026 · Company Update / Clarification
Newspaper Advertisement of the Audited Financial Results for the Quarter and year ended 31st March 20261 Jun 2026 · Company Update / Newspaper Publication
Submission of Integrated Filing of Financials for the Quarter and FY ended 31st March, 202629 May 2026 · Result / Financial Results
Submission of Financial Results for the Quarter and FY ended 31st March, 202629 May 2026 · Result / Financial Results
Pursuant to Regulation 30 read with Regulation 33 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015, we would like to inform you that the meeting of Board of Directors ....29 May 2026 · Board Meeting / Outcome of Board Meeting
Phaarmasia Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve 1. To consider, review, approve, ....22 May 2026 · Board Meeting / Board Meeting
Certificate under Reg 74(5) of SEBI(Depositories and Participants) Reg, 2018 for the quarter and Year Ended 31st march 2026.17 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
The Exchange has Sought Clarification on Price Movement with reference to Significant Movement in Price, in Order to Ensure that Investors have Latest Information about the company, So ....15 Apr 2026 · Company Update / General
Intimation of Change in the Registered Office of the Company within the Local Limits of City15 Apr 2026 · Company Update / Change in Registered Office Address
The Exchange has sought clarification from Phaarmasia Ltd on April 13, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant information ....13 Apr 2026 · Company Update / Clarification
Closure of Trading window under Reg 30 of SEBI (LODR) Reg 2015 for the Quarter and Financial year ended 31st March 202627 Mar 2026 · Insider Trading / SAST / Closure of Trading Window
Newspaper Advertisement of unaudited Financial results for the Quarter ended 31st December, 20259 Feb 2026 · Company Update / Newspaper Publication
Submission of integrated Financials for the Quarter ended 31st December, 20256 Feb 2026 · Result / Financial Results
Submission of Financial results for the Quarter ended 31st December 20256 Feb 2026 · Result / Financial Results
Submission of Outcome of Board Meeting held on Friday, 06th February, 2026 at 05.00 PM for the Quarter ended 31 December 20256 Feb 2026 · Board Meeting / Outcome of Board Meeting
Phaarmasia Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 ,inter alia, to consider and approve 1. To consider, approve and take ....2 Feb 2026 · Board Meeting / Board Meeting
Certificate under Reg 74(5) of SEBI(Depositories and Participants) Regulations, 2018 for the Quarter ended 31st December, 202516 Jan 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Closure of trading Window for dealing in the securities of the company will remain closed from January 01st, 2026 till 48hrs of the declaration of unaudited Financial Statements for the ....29 Dec 2025 · Insider Trading / SAST / Closure of Trading Window
Newspaper Publication of the Unaudited Financial Results for the Quarter and Half Year Ended 30th September 2025.15 Nov 2025 · Company Update / Newspaper Publication
Submission of Unaudited Financial results for the Quarter and Half Year Ended 30th September 202514 Nov 2025 · Result / Financial Results
Submission of Unaudited Financial Results for the Quarter and Half Year Ended 30th September 202514 Nov 2025 · Result / Financial Results
Outcome of Board Meeting held on Friday, 14th November, 2025 to approve the unaudited Financial Statement for the Quarter and Half year ended 30th September, 2025.14 Nov 2025 · Board Meeting / Outcome of Board Meeting
Newspaper Publication regarding special Window for re-lodgement of transfer requests of physical Shares.13 Nov 2025 · Company Update / Newspaper Publication
Phaarmasia Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve 1. To consider, approve and take ....7 Nov 2025 · Board Meeting / Board Meeting
Certificate under Reg 74(5) of SEBI (Depositories and participants) Reg, 2018 for the Quarter and half year ended 30th September, 202518 Oct 2025 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Submission of Outcome of Board meeting held on Monday, 13th October, 2025 at 05.00 PM (IST) through Audio Video Visual means.13 Oct 2025 · Others / Outcome without intimation

Board meetings

13 Aug 2026 Board Meeting - Financial Results